Remove Clinical Research Remove Development Remove Life Science Remove Trials
article thumbnail

How the New EU AI Act Will Impact Clinical Trials in the Life Sciences?

Cloudbyz

This Act is poised to significantly change the clinical trials landscape within the life sciences sector. As AI increasingly becomes a cornerstone in clinical research and drug development, it is crucial for industry stakeholders to grasp the extensive implications of this regulation.

article thumbnail

The Winning Formula For Life Sciences: Salesforce Life Sciences Cloud And Cloudbyz eClinical Solutions Collaboration

Cloudbyz

In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Life Science Trends for 2024 – Xtalks Life Science Podcast Ep. 143

XTalks

In this episode, Ayesha talked about some of the trends in the life sciences to watch out for in 2024. Hear about the latest technologies and approaches that will help drive innovations in drug discovery, clinical research and medical device design this year.

article thumbnail

Bios launches biotech hub to support life science progress

Drug Discovery World

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. A real revolution in life science development.”

article thumbnail

Introduction of new drugs without local trial is unscientific & risky as patients here have different anthropometry: Experts

AuroBlog - Aurous Healthcare Clinical Trials blog

Experts in the life-sciences industry are of the view that doing away with human studies for new drugs in India is unscientific and risky as patients here have different anthropometry.

Trials 139
article thumbnail

New Frontiers in Epilepsy and Seizure Treatments ft. Dr. Jeremy Levin and Meg Alexander, Ovid Therapeutics – Xtalks Life Science Podcast Ep. 159

XTalks

Ovid Therapeutics is a biopharmaceutical company focused on the development of medicines for epilepsies and seizure-related neurological disorders. Prior to Ovid, she founded and led the Reputation & Risk Management Group, a consultancy within Syneos Health, one of the world’s largest clinical research organizations.

article thumbnail

Awakn Life Sciences receives UK backing for ketamine therapy  

Drug Discovery World

Biotechnology company Awakn Life Sciences has received funding from Innovate UK to help it advance its ketamine-assisted therapy programme to market in the UK and US. . Awakn Life Sciences has developed a ketamine-assisted therapy programme for treating alcohol use disorder (AUD). Official comments .